Paraplatin and Cytotec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paraplatin (carboplatin) and Cytotec (misoprostol). Common drug interactions include anaphylactic shock among females and intestinal perforation among males.

The phase IV clinical study analyzes what interactions people have when they take Paraplatin and Cytotec. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.

What is Cytotec?

Cytotec has active ingredients of misoprostol. It is often used in abortion. eHealthMe is studying from 5,812 Cytotec users. Check the latest studies of Cytotec.

On Jul, 21, 2026

26 people who take Paraplatin and Cytotec together, and have interactions are studied.

Paraplatin and Cytotec drug interactions.

What are the common drug interactions of Paraplatin and Cytotec, by gender? *:

female:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Eosinophil count increased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pleural effusion (water on the lungs)
Cough
Pneumonia
Pyrexia (fever)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bone marrow failure
Cardiac failure

male:

Intestinal perforation (complete penetration of the wall of the intestine)
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood lactate dehydrogenase increased
Blood pressure decreased
Bowel movement irregularity
C-reactive protein increased
Chest pain
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Paraplatin and Cytotec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Eosinophil count increased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia
Bone marrow failure
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Alopecia (absence of hair from areas of the body)
Anxiety
Dyspnoea (difficult or laboured respiration)
Emotional distress

50-59:

Tendon pain
Cardiac arrest
Febrile neutropenia (fever with reduced white blood cells)

60+:

Pleural effusion (water on the lungs)
Cough
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
Lung adenocarcinoma (a form of non-small cell lung cancer)
Small intestine ulcer
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Abdominal pain
Abdominal rigidity
Abdominal tenderness
Amyloidosis (a tumour within which amyloid is produced)

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 11 people, 42.31%
High Blood Pressure: 8 people, 30.77%
Pain: 6 people, 23.08%
Cancer Pain: 5 people, 19.23%
Lung Adenocarcinoma Metastatic (a form of non-small cell lung cancer spreads to other part): 4 people, 15.38%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 15.38%
Cough: 4 people, 15.38%
Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 11.54%
Constipation: 3 people, 11.54%
Spinal Column Stenosis (narrowing of spinal column): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Paraplatin and Cytotec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously